Dr. Alousi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
- Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine/Pediatrics, 1997 - 2001
- Wayne State University School of MedicineClass of 1997
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- WA State Medical License 2023 - 2026
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Internal Medicine Hematology
- Join now to see all
Clinical Trials
- Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01
- Thymoglobulin (ATG) Dose Finding Study Start of enrollment: 2006 Dec 01
- Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (Ontak), and Pentostatin in Combination With Corticosteroids Start of enrollment: 2005 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 2855 citationsGut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patientsVancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews
Science. 2018-01-05 - 43 citationsBlood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Pr...Marcelo C. Pasquini, Brent R. Logan, Richard J. Jones, Amin M. Alousi, Frederick R. Appelbaum
Biology of Blood and Marrow Transplantation. 2018-06-01 - 130 citationsThree prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maravir...Javier Bolaños-Meade, Ran Reshef, Raphael Fraser, Mingwei Fei, Sunil Abhyankar
The Lancet. Haematology. 2019-03-01
Journal Articles
- Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
- Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
- A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
Abstracts/Posters
- Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaAmin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 OverexpressionAmin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS PatientsAmin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- 5 Things I Learned from My Non-Hodgkin’s Lymphoma TreatmentMay 14th, 2019
- ASBMT: A Model for Medical Self-GovernanceFebruary 26th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: